{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:00:03Z","timestamp":1753891203397,"version":"3.41.2"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T00:00:00Z","timestamp":1599609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"DOI":"10.3389\/fmed.2020.00551","type":"journal-article","created":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T04:24:08Z","timestamp":1599625448000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Wnt Inhibitors and Bone Turnover Markers in Patients With Polymyalgia Rheumatica and Acute Effects of Glucocorticoid Treatment"],"prefix":"10.3389","volume":"7","author":[{"given":"Angelo","family":"Fassio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Adami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Idolazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Giollo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ombretta","family":"Viapiana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Vantaggiato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camilla","family":"Benini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Rossini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Dejaco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Gatti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,9,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1001\/jama.2016.5444","article-title":"Polymyalgia rheumatica and giant cell arteritis: a systematic review","volume":"315","author":"Buttgereit","year":"2016","journal-title":"JAMA."},{"key":"B2","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/nrrheum.2017.142","article-title":"Giant cell arteritis and polymyalgia rheumatica: current challenges and opportunities","volume":"13","author":"Dejaco","year":"2017","journal-title":"Nat Rev Rheumatol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"318","DOI":"10.3899\/jrheum.180324","article-title":"Permanent discontinuation of glucocorticoids in polymyalgia rheumatica is uncommon but may be enhanced by amino bisphosphonates","volume":"46","author":"Giollo","year":"2019","journal-title":"J Rheumatol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1007\/s40266-019-00705-5","article-title":"Pathogenesis, diagnosis and management of polymyalgia rheumatica","volume":"36","author":"Camellino","year":"2019","journal-title":"Drugs Aging."},{"key":"B5","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.devcel.2005.02.017","article-title":"Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation","volume":"8","author":"Glass","year":"2005","journal-title":"Dev Cell."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1242\/jcs.02883","article-title":"Wnt signalling in osteoblasts regulates expression of the receptor activator of NF\u03baB ligand and inhibits osteoclastogenesis in vitro","volume":"119","author":"Spencer","year":"2006","journal-title":"J Cell Sci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00223-013-9749-z","article-title":"Involvement of WNT\/\u03b2-catenin signaling in the treatment of osteoporosis","volume":"93","author":"Rossini","year":"2013","journal-title":"Calcif Tissue Int."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1136\/annrheumdis-2017-eular.2728","article-title":"In psoriatic arthritis Dkk-1 and PTH are lower than in rheumatoid arthritis and healthy controls","volume":"36","author":"Fassio","year":"2017","journal-title":"Clin Rheumatol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.intimp.2018.12.050","article-title":"Inhibition of tumor necrosis factor-alpha (TNF-alpha) in patients with early rheumatoid arthritis results in acute changes of bone modulators","volume":"67","author":"Fassio","year":"2018","journal-title":"Int Immunopharmacol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.intimp.2018.04.019","article-title":"The serum level of Dickkopf-1 in patients with rheumatoid arthritis: a systematic review and meta-analysis","volume":"59","author":"Ma","year":"2018","journal-title":"Int Immunopharmacol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s00223-019-00649-3","article-title":"Acute effects of glucocorticoid treatment, TNF\u03b1 or IL-6R blockade on bone turnover markers and Wnt inhibitors in early rheumatoid arthritis: a pilot study","volume":"106","author":"Fassio","year":"2020","journal-title":"Calcif Tissue Int"},{"key":"B12","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nrrheum.2012.153","article-title":"Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment","volume":"8","author":"Schett","year":"2012","journal-title":"Nat Rev Rheumatol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/nm1538","article-title":"Dickkopf-1 is a master regulator of joint remodeling","volume":"13","author":"Diarra","year":"2007","journal-title":"Nat Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1007\/s00223-012-9684-4","article-title":"Acute effects of glucocorticoids on serum markers of osteoclasts, osteoblasts, and osteocytes","volume":"92","author":"Brabnikova Maresova","year":"2013","journal-title":"Calcif Tissue Int."},{"key":"B15","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1093\/rheumatology\/kem030","article-title":"Compared clinical efficacy and bone metabolic effects of low-dose deflazacort and methyl prednisolone in male inflammatory arthropathies: a 12-month open randomized pilot study","volume":"46","author":"Saviola","year":"2007","journal-title":"Rheumatol Oxf Engl."},{"key":"B16","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1097\/BOR.0000000000000608","article-title":"Glucocorticoid-induced osteoporosis update","volume":"31","author":"Adami","year":"2019","journal-title":"Curr Opin Rheumatol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.ymed.2012.09.009","article-title":"2012 Provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology collaborative initiative","volume":"64","author":"Dasgupta","year":"2012","journal-title":"Arthritis Rheum"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1136\/annrheumdis-2015-207578","article-title":"2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology collaborative initiative","volume":"74","author":"Dejaco","year":"2015","journal-title":"Ann Rheum Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1136\/ard.2003.011379","article-title":"A disease activity score for polymyalgia rheumatica","volume":"63","author":"Leeb","year":"2004","journal-title":"Ann Rheum Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4081\/reumatismo.2016.870","article-title":"Guidelines for the diagnosis, prevention and management of osteoporosis","volume":"68","author":"Rossini","year":"2016","journal-title":"Reumatismo."},{"key":"B21","first-page":"77","article-title":"In patients with rheumatoid arthritis, Dickkopf-1 serum levels are correlated with parathyroid hormone, bone erosions and bone mineral density","volume":"33","author":"Rossini","year":"2015","journal-title":"Clin Exp Rheumatol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"5552","DOI":"10.3390\/ijms20225552","article-title":"Wnt Signaling and biological therapy in rheumatoid arthritis and spondyloarthritis","volume":"20","author":"Cici","year":"2019","journal-title":"Int J Mol Sci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"104354","DOI":"10.1016\/j.phrs.2019.104354","article-title":"Effects of biological and targeted synthetic DMARDs on bone loss in rheumatoid arthritis","volume":"147","author":"Orsolini","year":"2019","journal-title":"Pharmacol Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1530\/EC-19-0104","article-title":"Regulation of sclerostin in glucocorticoid-induced osteoporosis (GIO) in mice and humans","volume":"8","author":"Thiele","year":"2019","journal-title":"Endocr Connect."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1007\/s10067-017-3689-3","article-title":"Glucocorticoid therapy causes contradictory changes of serum Wnt signaling-related molecules in systemic autoimmune diseases","volume":"37","author":"Kawazoe","year":"2018","journal-title":"Clin Rheumatol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1007\/s10072-017-2964-z","article-title":"Negative impact of high cumulative glucocorticoid dose on bone metabolism of patients with myasthenia gravis","volume":"38","author":"Braz","year":"2017","journal-title":"Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"6241","DOI":"10.2174\/1381612823666170713104431","article-title":"New strategies for the prevention and treatment of systemic and local bone loss; from pathophysiology to clinical application","volume":"23","author":"Fassio","year":"2017","journal-title":"Curr Pharm Des."},{"key":"B28","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.bone.2014.12.004","article-title":"A joined role of canopy and reversal cells in bone remodeling\u2013lessons from glucocorticoid-induced osteoporosis","volume":"73","author":"Jensen","year":"2015","journal-title":"Bone."},{"key":"B29","doi-asserted-by":"publisher","first-page":"5867","DOI":"10.3390\/ijms20235867","article-title":"Osteoporosis in rheumatic diseases","volume":"20","author":"Adami","year":"2019","journal-title":"Int J Mol Sci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"65","DOI":"10.4081\/reumatismo.2016.878","article-title":"The negative bone effects of the disease and of chronic corticosteroid treatment in premenopausal women affected by rheumatoid arthritis","volume":"68","author":"Fassio","year":"2016","journal-title":"Reumatismo."},{"key":"B31","doi-asserted-by":"publisher","first-page":"35","DOI":"10.4081\/reumatismo.2018.1039","article-title":"Comorbidity in polymyalgia rheumatica","volume":"70","author":"Chatzigeorgiou","year":"2018","journal-title":"Reumatismo."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e000570","DOI":"10.1136\/rmdopen-2017-000570","article-title":"Serum osteopontin: a biomarker of disease activity and predictor of relapsing course in patients with giant cell arteritis. Potential clinical usefulness in tocilizumab-treated patients","volume":"3","author":"Prieto-Gonz\u00e1lez","year":"2017","journal-title":"RMD Open."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmed.2020.00551\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T04:24:10Z","timestamp":1599625450000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmed.2020.00551\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,9]]},"references-count":32,"alternative-id":["10.3389\/fmed.2020.00551"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2020.00551","relation":{},"ISSN":["2296-858X"],"issn-type":[{"type":"electronic","value":"2296-858X"}],"subject":[],"published":{"date-parts":[[2020,9,9]]},"article-number":"551"}}